Security key
00091F304
ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC)
CUSIP: 00091F304
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 785,330
- Total 13F value
- $2,387,168
- Share change
- +417,953
- SEC-reported price per share
- $3.04
- Number of holders
- 14
- Value change
- +$1,270,658
- Number of buys
- 12
- Number of sells
- 3
- Shares outstanding
- 17,410,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
14
Top holders
10
ABVC full security history
Ownership snapshot
Full 13F holder table
ABVC BIOPHARMA, INC. SEC filings
ABVC BIOPHARMA, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00091F304
Recent filing periods:
Ownership snapshot
Top reported holders of ABVC - ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Eugene Jiang
Disclosed value leader
Lind Global Fund II LP
Comparable rows
11/15
Latest evidence
10 Jul 2025
13D/G
3/4/5
13F
Lead comparable stake: 18%
4 rows are not safely comparable across share classes.
13D/G row: Eugene Jiang
Showing 1-6 of 15 holder rows.
Quick read
Eugene Jiang leads the comparable SEC ownership view at 18%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Eugene Jiang's linked filing trail.
Comparable ownership
Top 5
Eugene Jiang
18%
Lind Global Fund II LP
3.2%
VANGUARD GROUP INC
0.64%
GEODE CAPITAL MANAGEMENT, LLC
0.63%
XTX Topco Ltd
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Eugene Jiang |
13D/G
3/4/5
Chairman of the Board & CBO, Director
|
18%
|
$219,036
131,159 shares
|
$0 | 10 Jul 2025 |
| Lind Global Fund II LP |
13D/G
|
3.2%
|
$2,211,858
557,143 shares
|
-$3,048,392 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.64%
|
$248,161
111,533 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.63%
|
$245,859
110,499 shares
|
— | 30 Jun 2025 |
| XTX Topco Ltd |
13F
Company
|
0.3%
|
$117,091
52,625 shares
|
— | 30 Jun 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.24%
|
$92,796
41,706 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
785,330
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
9
Q3 2025 holders
14
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend